Homepage | CIDRAP
WEBUniversity of Minnesota http://twin-cities.umn.edu/ 612-625-5000
COVID-19 - CIDRAP
WEBContact Us. CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN. Email us
Osterholm Update - CIDRAP
WEB3 days ago — In "Only the Beginning," Dr. Osterholm and Chris Dall discuss the mpox public health emergency and the latest COVID-19 and H5N1 trends. Dr. Osterholm also answers an ID Query on COVID-19 vaccine access and commemorates the legacy of Ryan White.
Infectious Disease Topics A-Z - CIDRAP
WEBA comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
About CIDRAP | CIDRAP
WEBThe Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to ...
Study: Prolonged antibiotics common in COVID patients with and …
WEB3 days ago — Prolonged antibiotics were common in hospitalized COVID-19 patients with and without sepsis during the first 33 months of the pandemic, despite low rates of proven bacterial infection, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology.. For the study, researchers from Harvard Medical School and Brigham and Women's Hospital analyzed electronic health record data ...
Episode 146: A Seasonless Virus - CIDRAP
WEBIn "A Seasonless Virus," Dr. Osterholm and Chris Dall discuss the latest COVID-19 trends in the U.S. and around the world, provide an update on influenza and RSV activity, and …
Episode 167: A Coronavirus Dance - CIDRAP
WEBIn "A Coronavirus Dance," Dr. Osterholm and Chris Dall discuss the latest COVId trends, the upcoming winter respiratory virus season, and a UN meeting on antimicrobial …
COVID-19: The CIDRAP Viewpoint
WEBApr 30, 2020 — Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza. Kristine A. Moore, MD, MPH; Marc Lipsitch, DPhil; John M. Barry, MA; Michael T ...
Long-term trial data boosts case for newer drug-resistant TB
WEB4 days ago — Iuliia Mikhalitskaia / iStock. Extended follow-up on patients in a phase 3 clinical trial found that two bedaquiline-containing drug regimens for rifampicin-resistant tuberculosis (TB) maintained superiority compared with a 9-month injectable-based regimen at 132 weeks, researchers reported yesterday in the Lancet Respiratory Medicine.. The STREAM stage 2 trial randomized patients aged 15 ...